Viet­nam signs deal for treat­ing rare dis­eases

BioSpectrum (Asia) - - Regulatory News -

The Med­i­cal Ser­vices Ad­min­is­tra­tion, un­der the Min­istry of Health

(MoH), Govern­ment of Viet­nam and

Shire Singapore Ltd have signed a Mem­o­ran­dum of Un­der­stand­ing (MoU) in or­der to im­prove the di­ag­no­sis, treat­ment and man­age­ment of rare dis­eases in Viet­nam un­til 2023. The agree­ment is also ex­pected to help sup­port pro­fes­sional med­i­cal ed­u­ca­tion in the coun­try and de­velop a man­age­ment pro­gramme for rare dis­eases. Dur­ing the first stage,

MoH and Shire will work to­gether to de­velop a na­tional guide­line to im­prove the qual­ity of di­ag­nos­tics, treat­ment and man­age­ment of Hae­mophilia and Pelvic In­flam­ma­tory Dis­ease (PID) as well as to sup­port pol­icy devel­op­ment on rare dis­eases in Viet­nam. Ac­cord­ing to the World Health Or­gan­i­sa­tion

(WHO), there are ap­prox­i­mately 100 rare dis­eases re­ported in Viet­nam.

It is es­ti­mated that al­most one in 15 per­sons, or ap­prox­i­mately six mil­lion peo­ple in the coun­try, suf­fer from a rare dis­ease. Viet­nam has more than 6,000 hae­mophilia pa­tients, but only 2,400 have been de­tected their dis­ease sit­u­a­tion, while PID re­mains com­mon and ad­versely af­fects the prog­no­sis of these pa­tients.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.